Updated efficacy and safety results from phase 1 and phase 2 studies for AVR-RD-01, an investigational lentiviral gene therapy for Fabry disease

被引：0
|
作者：
Thomas, Mark [1 ]
机构：
[1] Royal Perth Hosp, Perth, Australia
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2021.11.316
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
301
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [41] LENTIVIRAL-MEDIATED GENE THERAPY FOR SEVERE PYRUVATE KINASE DEFICIENCY: RESULTS FROM AN ONGOING GLOBAL PHASE 1 STUDY
    Lopez Lorenzo, Jose Luis
    Shah, Ami
    Sevilla, Julian
    Navarro, Susana
    Llanos, Lucia
    de Camino Gaisse, Begona Perez
    Sanchez, Sol
    Zubicaray, Josune
    Glader, Bertil
    Chien, May
    Quintana Bustamante, Oscar
    Zeini, Miriam
    Choi, Grace
    Nicoletti, Eileen
    Rao, Gayatri
    Roncarolo, Maria Grazia
    Bueren, Juan
    Schwartz, Jonathan
    Carlos Segovia, Jose
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 275 - 276
  • [42] EFFICACY AND SAFETY OF GUSELKUMAB THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS OF THE GALAXI 2 & 3 PHASE 3 STUDIES
    Panaccione, Remo
    Danese, Silvio
    Feagan, Brian G.
    D'Haens, Geert
    Afzali, Anita
    Reinisch, Walter
    Panes, Julian
    Rubin, David T.
    Andrews, Jane M.
    Hisamatsu, Tadakazu
    Terry, Natalie A.
    Salese, Leonardo
    Van Rampelbergh, Rian
    Frustaci, Mary Ellen S.
    Yang, Zijiang
    Johanns, Jewel
    Wan, Kitty Y.
    Yee, Jacqueline
    Sands, Bruce E.
    GASTROENTEROLOGY, 2024, 166 (05)
  • [43] Efficacy And Safety of Guselkumab Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results of the Galaxi 2 & 3 Phase 3 Studies
    Panaccione, Remo
    Danese, Silvio
    Feagan, Brian G.
    D'Haens, Geert
    Afzali, Anita
    Reinisch, Walter
    Panes, Julian
    Rubin, David T.
    Andrews, Jane
    Hisamatsu, Tadakazu
    Terry, Natalie A.
    Salese, Leonardo
    Van Rampelbergh, Rian
    Frustaci, Mary Ellen
    Yang, Zijiang
    Johanns, Jewel
    Wan, Kitty Yuen Yi
    Yee, Jacqueline
    Sands, Bruce E.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2312 - 2318
  • [44] Fabry Disease Mutations Addressable with Migalastat HCl, an Investigational Chaperone Therapy. Screening Results from FACETS, a Phase 3 Study in Male and Female Patients
    Bichet, Daniel
    Boudes, Pol
    El Din, Sharaf
    Ezgu, Fatih
    Feliciani, Claudio
    Zampetti, Anna
    Lourenco, Charles Marques
    Nicholls, Kathy
    Castelli, Jeff
    Overton, Chemise
    Sitaraman, Sheela
    Benjamin, Elfrida
    Wu, Xiaoyang
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S21 - S21
  • [45] Spk-8011: Preliminary Results from a Phase 1/2 Dose Escalation Trial of an Investigational AAV-Mediated Gene Therapy for Hemophilia a
    George, Lindsey A.
    Ragni, Margaret V.
    Samelson-Jones, Ben J.
    Cuker, Adam
    Runoski, Alexa R.
    Cole, Grace
    Wright, Fraser
    Chen, Yifeng
    Hui, Daniel J.
    Wachtel, Katie
    Takefman, Daniel
    Couto, Linda B.
    Reape, Kathleen Z.
    Carr, Marcus E.
    Anguela, Xavier M.
    High, Katherine A.
    BLOOD, 2017, 130
  • [46] Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial results after 4 years of treatment
    Lukina, Elena
    Watman, Nora
    Dragosky, Marta
    Pastores, Gregory M.
    Arreguin, Elsa Avila
    Rosenbaum, Hanna
    Zimran, Ari
    Angell, Jennifer
    Ross, Leorah
    Puga, Ana Cristina
    Peterschmitt, Judith M.
    BLOOD CELLS MOLECULES AND DISEASES, 2014, 53 (04) : 274 - 276
  • [47] Updated Safety and Efficacy Results From a Phase 2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab for Frontline Treatment of Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 6 - 7
  • [48] Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 HGB-206 Study
    Mapara, Markus Y.
    Tisdale, John F.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Francis J., Jr.
    Bonner, Melissa
    Huang, Wenmei
    Ribeil, Jean-Antoine
    Thompson, Alexis A.
    Walters, Mark C.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 78 - 79
  • [49] Lentiglobin for Sickle Cell Disease (SCD) Gene Therapy (GT): Updated Results in Group C Patients from the Phase 1/2 Hgb-206 Study
    Walters, Mark C.
    Kanter, Julie
    Kwiatkowski, Janet L.
    Krishnamurti, Lakshmanan
    Mapara, Markus Y.
    Schmidt, Manfred
    Miller, Alexandra L.
    Pierciey, Jr. Francis J.
    Bonner, Melissa
    Huang, Wenmei
    Ribeil, Jean-Antoine
    Thompson, Alexis A.
    Tisdale, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S1 - S2
  • [50] Efficacy and Safety of ≤200 mg Avapritinib in Patients with Advanced Systemic Mastocytosis: Pooled Results from the Phase 1 EXPLORER and Interim Phase 2 PATHFINDER Studies
    Radia, Deepti
    DeAngelo, Daniel
    Deininger, Michael W.
    Reiter, Andreas
    Sen, Jayita
    Lin, Hui Min
    Dimitrijevic, Sasa
    Gotlib, Jason
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S367 - S368
12345